Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
H. Miles Prince(The University of Melbourne), Youn H. Kim(Cancer Prevention Institute of California), Sarah McCue Horwitz(Memorial Sloan Kettering Cancer Center), Reinhard Dummer(University Hospital of Zurich), Julia Scarisbrick(NIHR Surgical Reconstruction and Microbiology Research Centre), Pietro Quaglino(University of Turin), Pier Luigi Zinzani(University of Bologna), Pascal Wolter(KU Leuven), José Antônio Sanches(Universidade de São Paulo), Pablo L. Ortiz‐Romero(Research Institute Hospital 12 de Octubre), Oleg E. Akilov(University of Pittsburgh), Larisa J. Geskin(University of Pittsburgh), Judith Trotman(The University of Sydney), Kerry Taylor(Cancer Council Queensland), Stéphane Dalle(Université Claude Bernard Lyon 1), Michael Weichenthal(University Hospital Schleswig-Holstein), Jan Walewski(The Maria Sklodowska-Curie National Research Institute of Oncology), David C. Fisher(Dana-Farber Cancer Institute), Brigitte Dréno(Nantes Université), Rudolf Stadler(Johannes Wesling Klinikum Minden), Tatyana Feldman(Hackensack University Medical Center), Timothy M. Kuzel(Rush University), Yinghui Wang(Seagen (United States)), Maria Corinna Palanca-Wessels(Seagen (United States)), Erin Zagadailov(Takeda (United States)), William L. Trepicchio(Takeda (United States)), Wenwen Zhang(Takeda (United States)), Huimin Lin(Takeda (United States)), Yi Liu(Takeda (United States)), Dirk Huebner(Takeda (United States)), Meredith Little(Takeda (United States)), Sean Whittaker(Guy's and St Thomas' NHS Foundation Trust), Madeleine Duvic(The University of Texas MD Anderson Cancer Center), Judith Trotman(The University of Sydney), David Joske(Dana-Farber Cancer Institute), H. Miles Prince(The University of Melbourne), Kerry Taylor(Cancer Council Queensland), Ian D. Lewis, Constanze Jonak, Franz Trautinger, Oliver Bechter, Pascal Wolter(KU Leuven), Dominique Bron, Vladmir Cláudio Cordeiro de Lima, José Antônio Sanches(Universidade de São Paulo), Richard Klasa, M. Bagot, M. Beylot‐Barry, Stéphane Dalle(Université Claude Bernard Lyon 1), M. D’Incan, Brigitte Dréno(Nantes Université), Florent Grange, Jan P. Nicolay(The Maria Sklodowska-Curie National Research Institute of Oncology), Rudolf Stadler(Johannes Wesling Klinikum Minden), Michael Weichenthal(University Hospital Schleswig-Holstein), Marion Wobser, Chalid Assaf, Carmen Loquai, Pietro Quaglino(University of Turin), Michele Spina, Pier Luigi Zinzani(University of Bologna), Alberto Bosi, Pier Paolo Fattori, Aleksandra Grzanka, Jan Walewski(The Maria Sklodowska-Curie National Research Institute of Oncology), Andrés López‐Hernandez, Pablo L. Ortiz‐Romero(Research Institute Hospital 12 de Octubre), José J. Rifón Roca, Silvana Novelli Canales, Reinhard Dummer(University Hospital of Zurich), Tim Illidge(Rush University), Rod Johnson, Sean Whittaker(Guy's and St Thomas' NHS Foundation Trust), Stephen Morris, Pam McKay, Julia Scarisbrick(NIHR Surgical Reconstruction and Microbiology Research Centre), Madeleine Duvic(The University of Texas MD Anderson Cancer Center), Tatyana Feldman(Hackensack University Medical Center), Oleg E. Akilov(University of Pittsburgh), Larisa J. Geskin(University of Pittsburgh), Steve Horwitz(Memorial Sloan Kettering Cancer Center), Youn H. Kim(Cancer Prevention Institute of California), Barbara Pro(The University of Texas MD Anderson Cancer Center), Timothy M. Kuzel(Rush University), Adam Lerner, Herbert Eradat, Lubomir Sokol, David C. Fisher(Dana-Farber Cancer Institute), S. Morgan Hughey
Cited by 577
Abstract
Related Papers
No related papers found
Powered by citation graph analysis